CEREDA, MATTEO
CEREDA, MATTEO
Dipartimento di Bioscienze
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors
2022 E. Berrino, R. Filippi, C. Visintin, S. Peirone, E. Fenocchio, G. Farinea, F. Veglio, M. Aglietta, A. Sapino, M. Cereda, R. Visintin, B. Pasini, C. Marchi(`(o))
HNRNPA2B1 controls an unfolded protein response-related prognostic gene signature in prostate cancer
2022 J. G Foster, E. Gea, M. A Labiba, C. A Anene, J. Stockley, C. Philippe, M. Cereda, K. Rouault-Pierre, H. Leung, C. Bessant, P. Rajan
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas
2022 E. Berrino, L. Annaratone, S.E. Bellomo, G. Ferrero, A. Gagliardi, A. Bragoni, D. Grassini, S. Guarrera, C. Parlato, L. Casorzo, M. Panero, I. Sarotto, S. Giordano, M. Cereda, F. Montemurro, R. Ponzone, N. Crosetto, A. Naccarati, A. Sapino, C. Marchiò
FOXA1 regulates alternative splicing in prostate cancer
2022 M. Del Giudice, J.G. Foster, S. Peirone, A. Rissone, L. Caizzi, F. Gaudino, C. Parlato, F. Anselmi, R. Arkell, S. Guarrera, S. Oliviero, G. Basso, P. Rajan, M. Cereda
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells
2022 R. Rotolo, V. Leuci, C. Donini, F. Galvagno, A. Massa, M.C. De Santis, S. Peirone, G. Medico, M. Sanlorenzo, I. Vujic, L. Gammaitoni, M. Basiricò, L. Righi, C. Riganti, I.C. Salaroglio, F. Napoli, F. Tabbò, A. Mariniello, E. Vigna, C. Modica, L. D'Ambrosio, G. Grignani, R. Taulli, E. Hirsch, M. Cereda, M. Aglietta, G.V. Scagliotti, S. Novello, P. Bironzo, D. Sangiolo
Precision medicine in osteosarcoma : MATCH trial and beyond
2021 E. Tirtei, A. Campello, S.D. Asaftei, K. Mareschi, M. Cereda, F. Fagioli
Artificial intelligence in bulk and single-cell rna-sequencing data to foster precision oncology
2021 M.D. Giudice, S. Peirone, S. Perrone, F. Priante, F. Varese, E. Tirtei, F. Fagioli, M. Cereda
Molecular characterization of prostate cancers in the precision medicine era
2021 E.F. Giunta, L. Annaratone, E. Bollito, F. Porpiglia, M. Cereda, G.L. Banna, A. Mosca, C. Marchio, P. Rescigno
Omic approaches to pediatric bone sarcomas
2020 E. Tirtei, M. Cereda, E. De Luna, P. Quarello, S.D. Asaftei, F. Fagioli
Identification of altered biological processes in heterogeneous RNA-sequencing data by discretization of expression profiles
2020 A. Lauria, S. Peirone, M.D. Giudice, F. Priante, P. Rajan, M. Caselle, S. Oliviero, M. Cereda
HaTSPiL : A modular pipeline for high throughput sequencing data analysis
2019 E. Morandi, M. Cereda, D. Incarnato, C. Parlato, G. Basile, F. Anselmi, A. Lauria, L.M. Simon, I.L. Polignano, F. Arruga, S. Deaglio, E. Tirtei, F. Fagioli, S. Oliviero
A comprehensive bioinformatics analysis of UBE2C in cancers
2019 H. Dastsooz, M. Cereda, D. Donna, S. Oliviero
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma
2019 T.P. Mourikis, L. Benedetti, E. Foxall, D. Temelkovski, J. Nulsen, J. Perner, M. Cereda, J. Lagergren, M. Howell, C. Yau, R.C. Fitzgerald, P. Scaffidi, A. Noorani, P.A.W. Edwards, R.F. Elliott, N. Grehan, B. Nutzinger, C. Hughes, E. Fidziukiewicz, J. Bornschein, S. Macrae, J. Crawte, A. Northrop, G. Contino, X. Li, R. de la Rue, A. Katz-Summercorn, S. Abbas, D. Loureda, M. O'Donovan, A. Miremadi, S. Malhotra, M. Tripathi, S. Tavare, A.G. Lynch, M. Eldridge, M. Secrier, L. Bower, G. Devonshire, S. Jammula, J. Davies, C. Crichton, N. Carroll, P. Safranek, A. Hindmarsh, V. Sujendran, S.J. Hayes, Y. Ang, A. Sharrocks, S.R. Preston, S. Oakes, I. Bagwan, V. Save, R.J.E. Skipworth, T.R. Hupp, J. Robert O'Neill, O. Tucker, A. Beggs, P. Taniere, S. Puig, T.J. Underwood, R.C. Walker, B.L. Grace, H. Barr, N. Shepherd, O. Old, J. Gossage, A. Davies, F. Chang, J. Zylstra, U. Mahadeva, V. Goh, G. Sanders, R. Berrisford, C. Harden, M. Lewis, E. Cheong, B. Kumar, S.L. Parsons, I. Soomro, P. Kaye, J. Saunders, L. Lovat, R. Haidry, L. Igali, M. Scott, S. Sothi, S. Suortamo, S. Lishman, G.B. Hanna, C.J. Peters, K. Moorthy, A. Grabowska, R. Turkington, D. Mcmanus, D. Khoo, W. Fickling, F.D. Ciccarelli
Dysregulation of splicing-related proteins in prostate cancer is controlled by FOXA1
2018 J. Gordon Foster, R. Arkell, M. Del Giudice, C. Anene, A. Lauria, J. Daniel Gerard Kelly, N. Robert Lemoine, S. Oliviero, M. Cereda, P. Rajan
Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1
2017 L. Benedetti, M. Cereda, L. Monteverde, N. Desai, F.D. Ciccarelli
MEGA-V : Detection of variant gene sets in patient cohorts
2017 G. Gambardella, M. Cereda, L. Benedetti, F.D. Ciccarelli
Genetic Redundancy, Functional Compensation, and Cancer Vulnerability
2016 M. Cereda, T.P. Mourikis, F.D. Ciccarelli
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes
2016 M. Cereda, G. Gambardella, L. Benedetti, F. Iannelli, D. Patel, G. Basso, R.F. Guerra, T.P. Mourikis, I. Puccio, S. Sinha, L. Laghi, J. Spencer, M. Rodriguez-Justo, F.D. Ciccarelli
RNAmotifs : Prediction of multivalent RNA motifs that control alternative splicing
2014 M. Cereda, U. Pozzoli, G. Rot, P. Juvan, A. Schweitzer, T. Clark, J. Ule
Deep sequencing of the X chromosome reveals the proliferation history of colorectal adenomas
2014 A. De Grassi, F. Iannelli, M. Cereda, S. Volorio, V. Melocchi, A. Viel, G. Basso, L. Laghi, M. Caselle, F.D. Ciccarelli